Characteristics of compounds that cross the blood-brain barrier
TLDR
Two examples of drug delivery for newly discovered transporters are discussed: that for phosphorothioate oligonucleotides and for enzymes.Abstract:
Substances cross the blood-brain barrier (BBB) by a variety of mechanisms. These include transmembrane diffusion, saturable transporters, adsorptive endocytosis, and the extracellular pathways. Here, we focus on the chief characteristics of two mechanisms especially important in drug delivery: transmembrane diffusion and transporters. Transmembrane diffusion is non-saturable and depends, on first analysis, on the physicochemical characteristics of the substance. However, brain-to-blood efflux systems, enzymatic activity, plasma protein binding, and cerebral blood flow can greatly alter the amount of the substance crossing the BBB. Transport systems increase uptake of ligands by roughly 10-fold and are modified by physiological events and disease states. Most drugs in clinical use to date are small, lipid soluble molecules that cross the BBB by transmembrane diffusion. However, many drug delivery strategies in development target peptides, regulatory proteins, oligonucleotides, glycoproteins, and enzymes for which transporters have been described in recent years. We discuss two examples of drug delivery for newly discovered transporters: that for phosphorothioate oligonucleotides and for enzymes.read more
Citations
More filters
Journal ArticleDOI
Intranasal delivery of biologics to the central nervous system
TL;DR: An overview of relevant nasal anatomy and physiology is given and the pathways and mechanisms likely involved in drug transport from the nasal epithelium to the CNS are discussed.
Journal ArticleDOI
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
TL;DR: A deeper understanding of the BBB and BTB through the application of single-cell sequencing and imaging techniques, and the development of biomarkers of BBB integrity along with systems biology approaches, should enable new personalized treatment strategies for primary brain malignancies and brain metastases.
Journal ArticleDOI
Current Strategies for Brain Drug Delivery.
TL;DR: This review re-visits, according to recent publications, some questions that are controversial, such as whether nanoparticles by themselves could cross the BBB and whether drugs are specifically transferred to the brain by actively targeted nanoparticles.
Journal ArticleDOI
Current Challenges and Opportunities in Treating Glioblastoma
TL;DR: Novel drug delivery methods, including nanoparticles and prodrugs and computational multi-parameter optimization to assess the blood-brain barrier (BBB) permeability of small molecules in clinical trials for GBM treatment are discussed.
Journal ArticleDOI
New Strategies for the Transition-Metal Catalyzed Synthesis of Aliphatic Amines.
TL;DR: This review aims to provide a concise overview of modern transition-metal catalyzed approaches to alkylamine synthesis and their functionalization.
References
More filters
Journal ArticleDOI
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
TL;DR: Experimental and computational approaches to estimate solubility and permeability in discovery and development settings are described in this article, where the rule of 5 is used to predict poor absorption or permeability when there are more than 5 H-bond donors, 10 Hbond acceptors, and the calculated Log P (CLogP) is greater than 5 (or MlogP > 415).
Journal ArticleDOI
Fine structural localization of a blood-brain barrier to exogenous peroxidase
TL;DR: These findings localize, at a fine structural level, a "barrier" to the passage of peroxidase at the endothelium of vessels in the cerebral cortex in mice, particularly with reference to a recent study in which similar techniques were applied to capillaries in heart and skeletal muscle.
Journal ArticleDOI
Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection
TL;DR: Saturability of D-glucose uptake was demonstrated and evidence presented that all of the five hexoses measurably taken up by brain shared a common carrier, two blood-brain barrier carrier systems for amino acids.
Journal ArticleDOI
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
Matthew J. During,Lei Cao,David S. Zuzga,Jeremy S. Francis,Helen L. Fitzsimons,Xiangyang Jiao,Ross J. Bland,Matthias Klugmann,William A. Banks,Daniel J. Drucker,Colin N. Haile +10 more
TL;DR: Systemic administration of [Ser(2)]exendin(1–9) in wild-type animals prevents kainate-induced apoptosis of hippocampal neurons and represents a promising new target for both cognitive-enhancing and neuroprotective agents.
Journal ArticleDOI
Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability
TL;DR: The rat brain capillary permeability coefficient was determined for 27 compounds and the relationship of permeability to octanol/water partition coefficient and molecular weight was found to be predictable for drugs with molecular weights less than 400.